AI Research, Innovation, and Accountability Act: What Research Offices Need to Know

The AI Research, Innovation, and Accountability Act (AIRIA, S.3312) was a bipartisan US Senate bill that would have created federal risk tiers, transparency reporting, and certification duties for high-impact AI systems. It cleared the Senate Commerce Committee in July 2024 but died when the 118th Congress adjourned in January 2025. Its framework has not disappeared, however: near-identical risk-tier and disclosure ideas now surface in state AI statutes, in federal agency guidance, and in follow-on bills before the 119th Congress — several of which already touch how NIH and NSF handle AI in grant review.

AIRIA is a defined legislative proposal, not a law currently in force: it is the bill that proposed classifying AI systems as “high-impact” or “critical-impact” and tasking the National Institute of Standards and Technology (NIST) with testing, evaluation, validation, and verification standards for the highest-risk category.

What is the AI Research, Innovation, and Accountability Act?

The AI Research, Innovation, and Accountability Act is a US Senate bill introduced on 15 November 2023 by Senators John Thune (R-SD), Amy Klobuchar (D-MN), Roger Wicker (R-MS), John Hickenlooper (D-CO), Shelley Moore Capito (R-WV), and Ben Ray Luján (D-NM). It proposed a risk-based federal framework rather than blanket rules for all AI.

Core provisions included:

• A two-tier risk classification for “high-impact” and “critical-impact” AI systems used in consequential decisions.
• Mandatory transparency reports and risk assessments from developers and deployers of the highest-risk systems.
• A NIST-led programme to develop testing, evaluation, validation, and verification (TEVV) standards.
• A certification and enforcement structure housed at the Department of Commerce.
• A consumer-education and industry working-group mandate to support voluntary compliance ahead of formal rules.

Unlike the EU’s comprehensive AI Act, AIRIA targeted only the highest-risk use cases and left most research and low-risk commercial AI activity outside its scope.

What happened to AIRIA in Congress?

AIRIA advanced further than most AI bills of its era but still did not become law. The Senate Committee on Commerce, Science, and Transportation ordered it reported on 31 July 2024, and the Congressional Budget Office published a cost estimate on 6 December 2024. Under standard congressional procedure, any bill not enacted before a Congress ends is considered dead; AIRIA lapsed with the close of the 118th Congress on 3 January 2025 and was not carried forward automatically.

That is not the end of the story. Several bills before the 119th Congress (2025–2026) reuse AIRIA’s building blocks — including the AI Accountability Act (H.R.1694), which directs a federal study of AI accountability measures, and the Future of Artificial Intelligence Innovation Act of 2026 (S.3952), which revives the NIST standards-and-evaluation mandate AIRIA proposed. None of these has replicated AIRIA in full, but the pattern is consistent: risk tiers, NIST-run testing standards, and disclosure duties keep reappearing in federal drafting, which is why the original bill remains a useful reference text even though it never passed.

How does AIRIA interact with NIH and NSF grant compliance?

AIRIA itself never reached the funding agencies, but the compliance gap it targeted — undisclosed or unaccountable AI use in high-stakes review processes — is already being filled through agency policy rather than statute. Research offices do not need AIRIA to pass to feel its logic in practice.

• NIH issued NOT-OD-23-149, prohibiting NIH scientific peer reviewers from uploading grant application or critique content into generative AI tools, to protect peer-review confidentiality and integrity.
• NSF issued a parallel notice on 14 December 2023 barring reviewers from entering proposal or review information into non-approved generative AI tools, with corresponding updates folded into the Proposal & Award Policies and Procedures Guide (PAPPG).
• OMB Memorandum M-24-10, issued 28 March 2024, requires every CFO Act agency — including the parent departments of NIH and NSF — to designate a Chief AI Officer, convene an AI governance board, inventory AI use cases annually, and publish compliance plans.

Research administrators should read AIRIA less as a future obligation and more as the missing statutory layer above rules that funders have already implemented administratively. If AIRIA-style provisions are eventually enacted, they would most plausibly formalise — not replace — the NIH and NSF confidentiality prohibitions and the OMB governance-board model that are already operating today.

How does AIRIA compare with state AI laws and the EU AI Act?

Research institutions rarely operate under one AI framework. Multi-state university systems, international co-investigators, and federally funded projects with EU partners are simultaneously exposed to federal inaction, an unsettled state landscape, and a phased EU regime.

The Colorado reversal is the clearest recent signal: SB 24-205 was the first comprehensive US state AI law, but Colorado Governor Jared Polis signed its full replacement, SB 26-189, on 14 May 2026 — meaning the original statute never actually took effect. State AI law is moving fast and is not stable enough to treat any single statute as a durable compliance target.

Common questions research administrators ask

What is the AI Research, Innovation, and Accountability Act?

It is a 2023 US Senate bill (S.3312) that proposed risk-tiered federal oversight of “high-impact” and “critical-impact” AI systems, including NIST-led testing standards and mandatory transparency reporting. It advanced through Senate Commerce Committee review in 2024 but was never enacted.

What is the AI legislation situation in 2026?

No single comprehensive federal AI statute exists in the United States as of mid-2026. Oversight instead comes from a patchwork of agency guidance (OMB M-24-10, NIH and NSF notices), a shifting set of state statutes (Texas TRAIGA in effect, Colorado’s law repealed and replaced), and several competing federal bills still in committee.

What are the seven principles referenced in AI regulatory frameworks?

Frameworks such as the EU AI Act commonly cite human agency and oversight, technical robustness and safety, privacy and data governance, transparency, non-discrimination and fairness, societal and environmental wellbeing, and accountability. AIRIA did not adopt this exact list but pursued the same accountability and transparency goals through US-specific risk tiers.

Why research offices should track this now

Waiting for a federal AI bill to pass before building internal AI-use policy is the wrong sequencing. NIH and NSF already enforce confidentiality rules on generative AI in peer review, OMB already requires agency AI governance boards, and state rules are changing faster than any single institution can absorb reactively — Colorado’s reversal took less than two years from enactment to repeal.

Research offices should treat AIRIA as a design template, not a deadline. Institutions that map their existing AI-use disclosure practices against AIRIA’s risk-tier and TEVV concepts now will be positioned to adapt quickly if a successor bill — whether H.R.1694, S.3952, or a future proposal — advances further than AIRIA did. The direction of travel across federal agency guidance, state law, and the EU AI Act is consistent even where the US federal statute itself has stalled: more disclosure, more documented risk assessment, and more named institutional accountability for AI used in decisions that affect people’s funding, careers, and research records.

For related compliance context, see CASRAI’s research administration resources and the CASRAI Dictionary for definitions of adjacent governance and compliance terms.